newsfilter
← Latest News
GlobeNewswire·

NexImmune Reports Fiscal Year 2020 Financial Results and Recent Updates

In 2020, advanced two product candidates into Phase 1/2 clinical trials while strengthening Board of Directors and management teamCompleted successful $126M initial public offering (IPO) in February...